Case report: Fatal mesenteric and retroperitoneal serositis after pelvic chemoradiation followed by a single dose of chemotherapy and nivolumab

by Aaron Sulkes, Yulia Kundel, Eran Sadot, Pierre Singer, Victoria Neiman, Liudmila Fridel, Marva Harpak, Hanoch Kashtan, Baruch Brenner
Published 2020-12-01

The association between smoking and breast cancer characteristics and outcome

by Hadar Goldvaser, Omer Gal, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi
Published 2017-09-01

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics

by Hadar Goldvaser, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi
Published 2016-01-01

Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis.

by Rinat Yerushalmi, Hadar Goldvaser, Aaron Sulkes, Irit Ben-Aharon, Daniel Hendler, Victoria Neiman, Noa Beatrice Ciuraru, Luisa Bonilla, Limor Amit, Alona Zer, Tal Granot, Shulamith Rizel, Salomon M Stemmer
Published 2014-01-01

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock

by Osnat Itzhaki Ben Zadok, MD, MS, Ben Ben-Avraham, MD, Anju Nohria, MD, Katia Orvin, MD, Mithal Nassar, MD, Zaza Iakobishvili, MD, PhD, Victoria Neiman, MD, Hadar Goldvaser, MD, Ran Kornowski, MD, Tuvia Ben Gal, MD
Published 2019-09-01

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis

by Keren Rouvinov, Keren Rouvinov, Eran Levanon, Avivit Peer, Michal Sarfaty, David Sarid, Victoria Neiman, Eduard Grikshtas, Eli Rosenbaum, Igal Kushnir, Barak Talmor, Michael Friger, Yonaton Zarbiv, Eli Gez, Hadas Dresler, Walid Shalata, Amichay Meirovitz, Amichay Meirovitz, Noa Shani Shrem, Alexander Yakobson, Alexander Yakobson, Wilmosh Mermershtain, Daniel Keizman
Published 2023-05-01

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random...

by Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Published 2020-07-01